Advertisement
Advertisement

STXS

STXS logo

Stereotaxis Inc

2.30
USD
-0.07
-2.95%
Dec 18, 15:27 UTC -5
Open

Stereotaxis Inc Profile

About

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters, guidewires and stent delivery devices through the blood vessels and chambers of the heart to treatment sites.

Info & Links

CEO

David L. Fischel

Headquarters

710 North Tucker Boulevard, Suite 110
ST.LOUIS, MO 63101, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

419

Employees

122

Stereotaxis Inc Statistics

Valuation Measures

Market Capitalization2

194.88M

Enterprise Value

183.87M

Enterprise Value/EBITDA(ttm)

-8.48

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

7.89

Price to Book(mrq)

18.32

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

58.95%

Operating Margin(ttm)

-85.79%

Profit Margin(ttm)

-98.95%

Return on Equity(ttm)

-162.54%

Return on Invested Capital(ttm)

-118.44%

Return on Assets(ttm)

-51.26%

Income Statement

Revenue(ttm)

25.14M

Revenue Per Share(ttm)

0.30

Gross Profit(ttm)

14.12M

EBITDA(ttm)3

-21.67M

Net Income Available to Common(ttm)

-22.89M

Diluted EPS(ttm)

-0.28

Share Statistics

Beta (5Y Monthly)

1.57

52-Week Change

31.43%

S&P 500 52-Week Change

25.64%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

84.73M

Dividend Yield

0.00%

Float4

69.04M

% Held by Insiders

18.52%

% Held by Institutions

45.35%

Balance Sheet

Total Cash(mrq)

11.01M

Total Cash Per Share(mrq)

0.13

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.39%

Quick Ratio(mrq)

0.96%

Book Value Per Share(mrq)

0.19

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.11

Free Cash Flow(ytd)

-9.79M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement